Author Correction: A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis.

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 Feb 2020
Historique:
entrez: 21 2 2020
pubmed: 23 2 2020
medline: 23 2 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41598-020-58956-x PMID: 32075984 PMC: PMC7031233
pubmed: 32075984
doi: 10.1038/s41598-020-58956-x
pii: 10.1038/s41598-020-58956-x
pmc: PMC7031233
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

3312

Commentaires et corrections

Type : ErratumFor

Auteurs

David Devos (D)

Department of Neurology, ALS Center, Lille University, INSERM UMRS_1171, University Hospital Center, LICEND COEN Center, Lille, France. david.devos@chru-lille.fr.
Department of Medical Pharmacology, Lille University, INSERM UMRS_1171, University Hospital Center, LICEND COEN Center, Lille, France. david.devos@chru-lille.fr.
ORCID: 0000-0002-2417-799X

Caroline Moreau (C)

Department of Neurology, ALS Center, Lille University, INSERM UMRS_1171, University Hospital Center, LICEND COEN Center, Lille, France.

Maeva Kyheng (M)

Department of Biostatistics, Lille University, University Hospital Center, Lille, France.

Guillaume Garçon (G)

Univ. Lille, CHU Lille, Institut Pasteur de Lille, EA4483 IMPECS-IMPact de l'Environnement Chimique sur la Santé humaine, Lille, France.

Anne Sophie Rolland (AS)

Department of Medical Pharmacology, Lille University, INSERM UMRS_1171, University Hospital Center, LICEND COEN Center, Lille, France.

Hélène Blasco (H)

Université François-Rabelais, Inserm U930, Laboratoire de Biochimie, CHRU de Tours, France.

Patrick Gelé (P)

CRB/CIC1403, Université de LILLE, Lille, France.

T Timothée Lenglet (TT)

APHP, Department of Neurophysiology, Pitié-Salpêtrière Hospital, Paris, France.

C Veyrat-Durebex (C)

Université François-Rabelais, Inserm U930, Laboratoire de Biochimie, CHRU de Tours, France.

Philippe Corcia (P)

Centre Constitutif SLA, Tours-Fédération des centres SLA Tours-Limoges, LitORALS, Tours, France.

Mary Dutheil (M)

Department of Medical Pharmacology, Lille University, INSERM UMRS_1171, University Hospital Center, LICEND COEN Center, Lille, France.

Peter Bede (P)

Biomedical Imaging Laboratory, CNRS, INSERM, Sorbonne University, Paris, France.
Computational Neuroimaging Group, Academic Unit of Neurology, Trinity College Dublin, Dublin, Ireland.

Andreas Jeromin (A)

Quanterix, Lexington, Massachusetts, USA.

Patrick Oeckl (P)

Department of Neurology, Ulm University Hospital, Oberer Eselsberg 45, 89081, Ulm, Ulm, Germany.

Markus Otto (M)

Department of Neurology, Ulm University Hospital, Oberer Eselsberg 45, 89081, Ulm, Ulm, Germany.
ORCID: 0000-0003-4273-4267

Vincent Meininger (V)

APHP, Department of Neurology, Paris ALS Center, Pitié Salpêtrière Hospital, Paris, France.

Véronique Danel-Brunaud (V)

Department of Neurology, ALS Center, Lille University, INSERM UMRS_1171, University Hospital Center, LICEND COEN Center, Lille, France.

Jean-Christophe Devedjian (JC)

Department of Medical Pharmacology, Lille University, INSERM UMRS_1171, University Hospital Center, LICEND COEN Center, Lille, France.

James A Duce (JA)

ALBORADA Drug Discovery Institute, University of Cambridge, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0AH, UK.
School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, West Yorkshire, United Kingdom.

Pierre François Pradat (PF)

Biomedical Imaging Laboratory, CNRS, INSERM, Sorbonne University, Paris, France.
APHP, Department of Neurology, Paris ALS Center, Pitié Salpêtrière Hospital, Paris, France.
Northern Ireland Centre for Stratified Medicine, Biomedical Sciences Research Institute Ulster University, C-TRIC, Altnagelvin Hospital, Derry/Londonderry, United Kingdom.

Classifications MeSH